In order to secure seamless growth engines, Ilyang Pharmaceutical is gearing up for the development of new drugs.
In a general shareholders meeting Friday, President Kim Dong-yeon said that the company will create opportunities to put out new antiviral drugs and biosimilar drugs.
He said that an additional study for antiulcer drug Nortec (ilaprazole), Korea’s 14th homegrown drug, has been...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.